Last reviewed · How we verify
Apotex generic fentanyl TDS
Apotex generic fentanyl TDS is a Small molecule drug developed by University of Maryland, Baltimore. It is currently FDA-approved. Also known as: Generic fentanyl TDS.
At a glance
| Generic name | Apotex generic fentanyl TDS |
|---|---|
| Also known as | Generic fentanyl TDS |
| Sponsor | University of Maryland, Baltimore |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Apotex generic fentanyl TDS CI brief — competitive landscape report
- Apotex generic fentanyl TDS updates RSS · CI watch RSS
- University of Maryland, Baltimore portfolio CI
Frequently asked questions about Apotex generic fentanyl TDS
What is Apotex generic fentanyl TDS?
Apotex generic fentanyl TDS is a Small molecule drug developed by University of Maryland, Baltimore.
Who makes Apotex generic fentanyl TDS?
Apotex generic fentanyl TDS is developed and marketed by University of Maryland, Baltimore (see full University of Maryland, Baltimore pipeline at /company/university-of-maryland-baltimore).
Is Apotex generic fentanyl TDS also known as anything else?
Apotex generic fentanyl TDS is also known as Generic fentanyl TDS.
What development phase is Apotex generic fentanyl TDS in?
Apotex generic fentanyl TDS is FDA-approved (marketed).
Related
- Manufacturer: University of Maryland, Baltimore — full pipeline
- Also known as: Generic fentanyl TDS
- Compare: Apotex generic fentanyl TDS vs similar drugs
- Pricing: Apotex generic fentanyl TDS cost, discount & access